טוען...
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use
Frequent genetic alterations discovered in FGFRs and evidence implicating some as drivers in diverse tumors has been accompanied by rapid progress in targeting FGFRs for anticancer treatments. Wider assessment of the impact of genetic changes on the activation state and drug responses is needed to b...
שמור ב:
הוצא לאור ב: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Impact Journals LLC
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5029699/ https://ncbi.nlm.nih.gov/pubmed/26992226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8132 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|